A crucial factor of regenerative medicine and drug investigation lies in the ability to expand human stem cell groups to sufficient numbers for therapeutic purposes. Traditionally, constrained cell availability posed a significant barrier to advancement in these fields. Consequently, considerable effort has been directed towards improving methods f